Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT00264225Phase 3Completed
Phase 3, randomised, double-blind trial of paracetamol + opium powder + caffeine in knee osteoarthritis (OA), sponsored by Solvay. Primary endpoint: Pain intensity assessed by Visual Analogue Scale at 10 days. Started Dec 2005; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT00264225.